臨床検査市場：検査タイプ、適応症、エンドユーザー別-2025-2030年の世界予測

臨床検査市場は、2023年に1,357億2,000万米ドルと評価され、2024年には1,453億1,000万米ドルに達すると予測され、CAGR 7.27%で成長し、2030年には2,218億6,000万米ドルに達すると予測されています。

臨床検査市場の範囲には、患者の健康状態を評価し、疾病の発見と予防を支援するために医療検査室で実施されるさまざまな診断およびモニタリング検査が含まれます。これらの検査には、ルーチンの血液検査、遺伝子検査、特殊な病理検査が含まれます。これらの検査の必要性は、タイムリーな診断、治療評価、健康モニタリングにおいて重要な役割を果たし、ヘルスケア提供者の臨床的意思決定をサポートすることにあります。その用途は病院、診療所、診断ラボ、調査機関に及び、エンドユーザーには正確な健康洞察を求めるヘルスケア専門家や患者が含まれます。市場の成長は主に、慢性疾患の有病率の上昇、高齢化、疾患の早期発見に対する需要の増加の影響を受けています。個別化医療の進展や、自動化、AIとビッグデータ解析の統合などの技術革新は、大きなビジネスチャンスをもたらします。企業はこれらの機会を活用するため、ユーザーフレンドリーでコスト効率の高い検査ソリューションの開発と新興国市場への進出に注力すべきです。しかし、規制遵守の問題、検査コストの高さ、生物医学データの複雑さなどが市場成長の課題となっています。また、特定の新規診断技術の信頼性に関しても不安があります。事業の成長が期待される革新的分野には、ポイントオブケア検査、家庭用検査キット、安全で効率的なデータ管理のためのブロックチェーンの統合などがあります。さらに、バイオマーカーに基づく検査を開発するための研究開発への投資は、精密医療の需要を満たすことができます。市場の競合情勢は、急速な技術進歩と主要企業間の戦略的提携によって特徴付けられます。全体として、市場の性質はダイナミックで競争が激しく、継続的なイノベーションが成長と差別化の道を示しています。利害関係者が関連性を維持し、効果的に競争するためには、規制動向や技術シフトに関する情報を機敏に入手し続けることが重要です。

市場力学：急速に進化する臨床検査市場の主要市場インサイトを公開

臨床検査市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的意思決定、新たなビジネスチャンスの獲得を行うことができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 慢性疾患の増加
  • 世界のヘルスケア支出の増加
  • 個別化医療への嗜好の高まり
• 市場抑制要因
  • 臨床検査に関連する高コスト
• 市場機会
  • ポイントオブケア検査のニーズの高まり
  • デジタルソリューションと臨床検査室検査の統合
• 市場の課題
  • 臨床検査に対する厳しい規制の枠組み

ポーターのファイブフォース：臨床検査市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：臨床検査市場における外部からの影響の把握

外部マクロ環境要因は、臨床検査市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析臨床検査市場における競合情勢の把握

臨床検査市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス臨床検査市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、臨床検査市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨臨床検査市場における成功への道筋を描く

臨床検査市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 慢性疾患の増加
    • 世界中でヘルスケア費が増加
    • 個別化医療への関心の高まり
  • 抑制要因
    • 臨床検査に関連する高コスト
  • 機会
    • ポイントオブケア検査の必要性の高まり
    • デジタルソリューションと臨床検査の統合
  • 課題
    • 臨床検査に関する厳格な規制枠組み
• 市場セグメンテーション分析
  • 検査の種類：基礎的な代謝情報をより包括的な視点で提供するため、包括的な代謝パネルの利用が拡大しています。
  • 適応症：予測分析と精密医療の重要性の高まりによる遺伝性疾患検査の進歩
  • エンドユーザー：より広範な範囲とコスト効率のため、独立した研究室が好まれる傾向が高まっている
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 臨床検査市場テストタイプ別

• 基礎代謝パネル
  • カルシウム
  • 電解質
  • グルコース
  • 腎臓検査
• 完全血球計算
• 包括的代謝パネル
  • 肝臓検査
  • タンパク質
• 脂質プロファイル
• 甲状腺検査
• 尿検査

第7章 臨床検査市場適応症別

• 自己免疫疾患
• 心血管疾患
• 遺伝性疾患
• 感染症
• 腫瘍性疾患

第8章 臨床検査市場：エンドユーザー別

• 病院内検査室
• 独立研究所

第9章 南北アメリカの臨床検査市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域の臨床検査市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカの臨床検査市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
  • LabcorpがOPKO HealthからBioReference Healthの主要資産を買収し、臨床および生殖医療サービスを全国に拡大
  • キープロテオ、早期遺伝性疾患スクリーニングのための新研究所を設立し新生児ケアを向上
  • BSIはネルソンラボと提携し、PPEサプライチェーンの合理化と世界の規制プロセスの簡素化を実現
  • オンクエスト・ラボラトリーズ、シュルティ・クリニカル・ラボラトリーと提携し、ムンバイでの高度な検査サービスを強化
  • レッドクリフ・ラボがメディセンターを買収、南ラジャスタン州での市場プレゼンスを強化し、全国的な成長を促進
  • クエスト・ダイアグノスティクス、ノーザン・ライト・ラボラトリーからの主要資産買収によりメイン州のヘルスケアを強化
• 戦略分析と提言

企業一覧

• Apollo Health and Lifestyle Limited
• Arup Laboratories Inc.
• Bioscientia Healthcare GmbH
• Biosino Bio-technology and Science Inc.
• Charles River Laboratories, Inc
• Cinven Ltd.
• Clinical Reference Laboratory, Inc.
• DaVita Inc. by UnitedHealth Group Inc.
• Dr Lal PathLabs Pvt. Ltd
• Eurofins Scientific SE
• Fresenius Medical Care Holdings, Inc.
• Laboratory Corporation of America Holdings
• LifeLabs
• Merck KgaA
• Metropolis Health Products Retail Pvt Ltd.
• Metropolis Healthcare
• Novartis International AG
• OPKO Health, Inc.
• PerkinElmer, Inc.
• Qiagen .N.V.
• Quest Diagnostics Incorporated
• Siemens Healthineers AG
• Sonic Healthcare Limited
• SYNLAB Group
• Thermo Fisher Scientific Inc.

LIST OF FIGURES

• FIGURE 1. CLINICAL LABORATORY TESTS MARKET RESEARCH PROCESS
• FIGURE 2. CLINICAL LABORATORY TESTS MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY TEST TYPE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY TEST TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS CLINICAL LABORATORY TESTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS CLINICAL LABORATORY TESTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES CLINICAL LABORATORY TESTS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES CLINICAL LABORATORY TESTS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC CLINICAL LABORATORY TESTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC CLINICAL LABORATORY TESTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA CLINICAL LABORATORY TESTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA CLINICAL LABORATORY TESTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. CLINICAL LABORATORY TESTS MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. CLINICAL LABORATORY TESTS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. CLINICAL LABORATORY TESTS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. CLINICAL LABORATORY TESTS MARKET DYNAMICS
• TABLE 7. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY BASIC METABOLIC PANEL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY CALCIUM, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY ELECTROLYTES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY GLUCOSE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY KIDNEY TESTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY BASIC METABOLIC PANEL, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY COMPLETE BLOOD COUNT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY COMPREHENSIVE METABOLIC PANEL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY LIVER TESTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY PROTEINS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY COMPREHENSIVE METABOLIC PANEL, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY LIPID PROFILE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY THYROID TEST, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY URINALYSIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY AUTOIMMUNE DISEASES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY GENETIC DISORDERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY ONCOLOGICAL DISEASES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 28. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 29. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY HOSPITAL-BASED LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 30. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY INDEPENDENT LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 31. AMERICAS CLINICAL LABORATORY TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 32. AMERICAS CLINICAL LABORATORY TESTS MARKET SIZE, BY BASIC METABOLIC PANEL, 2018-2030 (USD MILLION)
• TABLE 33. AMERICAS CLINICAL LABORATORY TESTS MARKET SIZE, BY COMPREHENSIVE METABOLIC PANEL, 2018-2030 (USD MILLION)
• TABLE 34. AMERICAS CLINICAL LABORATORY TESTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 35. AMERICAS CLINICAL LABORATORY TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 36. AMERICAS CLINICAL LABORATORY TESTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 37. ARGENTINA CLINICAL LABORATORY TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 38. ARGENTINA CLINICAL LABORATORY TESTS MARKET SIZE, BY BASIC METABOLIC PANEL, 2018-2030 (USD MILLION)
• TABLE 39. ARGENTINA CLINICAL LABORATORY TESTS MARKET SIZE, BY COMPREHENSIVE METABOLIC PANEL, 2018-2030 (USD MILLION)
• TABLE 40. ARGENTINA CLINICAL LABORATORY TESTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 41. ARGENTINA CLINICAL LABORATORY TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 42. BRAZIL CLINICAL LABORATORY TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 43. BRAZIL CLINICAL LABORATORY TESTS MARKET SIZE, BY BASIC METABOLIC PANEL, 2018-2030 (USD MILLION)
• TABLE 44. BRAZIL CLINICAL LABORATORY TESTS MARKET SIZE, BY COMPREHENSIVE METABOLIC PANEL, 2018-2030 (USD MILLION)
• TABLE 45. BRAZIL CLINICAL LABORATORY TESTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 46. BRAZIL CLINICAL LABORATORY TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 47. CANADA CLINICAL LABORATORY TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 48. CANADA CLINICAL LABORATORY TESTS MARKET SIZE, BY BASIC METABOLIC PANEL, 2018-2030 (USD MILLION)
• TABLE 49. CANADA CLINICAL LABORATORY TESTS MARKET SIZE, BY COMPREHENSIVE METABOLIC PANEL, 2018-2030 (USD MILLION)
• TABLE 50. CANADA CLINICAL LABORATORY TESTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 51. CANADA CLINICAL LABORATORY TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 52. MEXICO CLINICAL LABORATORY TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 53. MEXICO CLINICAL LABORATORY TESTS MARKET SIZE, BY BASIC METABOLIC PANEL, 2018-2030 (USD MILLION)
• TABLE 54. MEXICO CLINICAL LABORATORY TESTS MARKET SIZE, BY COMPREHENSIVE METABOLIC PANEL, 2018-2030 (USD MILLION)
• TABLE 55. MEXICO CLINICAL LABORATORY TESTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 56. MEXICO CLINICAL LABORATORY TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 57. UNITED STATES CLINICAL LABORATORY TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 58. UNITED STATES CLINICAL LABORATORY TESTS MARKET SIZE, BY BASIC METABOLIC PANEL, 2018-2030 (USD MILLION)
• TABLE 59. UNITED STATES CLINICAL LABORATORY TESTS MARKET SIZE, BY COMPREHENSIVE METABOLIC PANEL, 2018-2030 (USD MILLION)
• TABLE 60. UNITED STATES CLINICAL LABORATORY TESTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 61. UNITED STATES CLINICAL LABORATORY TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 62. UNITED STATES CLINICAL LABORATORY TESTS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 63. ASIA-PACIFIC CLINICAL LABORATORY TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 64. ASIA-PACIFIC CLINICAL LABORATORY TESTS MARKET SIZE, BY BASIC METABOLIC PANEL, 2018-2030 (USD MILLION)
• TABLE 65. ASIA-PACIFIC CLINICAL LABORATORY TESTS MARKET SIZE, BY COMPREHENSIVE METABOLIC PANEL, 2018-2030 (USD MILLION)
• TABLE 66. ASIA-PACIFIC CLINICAL LABORATORY TESTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 67. ASIA-PACIFIC CLINICAL LABORATORY TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 68. ASIA-PACIFIC CLINICAL LABORATORY TESTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 69. AUSTRALIA CLINICAL LABORATORY TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 70. AUSTRALIA CLINICAL LABORATORY TESTS MARKET SIZE, BY BASIC METABOLIC PANEL, 2018-2030 (USD MILLION)
• TABLE 71. AUSTRALIA CLINICAL LABORATORY TESTS MARKET SIZE, BY COMPREHENSIVE METABOLIC PANEL, 2018-2030 (USD MILLION)
• TABLE 72. AUSTRALIA CLINICAL LABORATORY TESTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 73. AUSTRALIA CLINICAL LABORATORY TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 74. CHINA CLINICAL LABORATORY TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 75. CHINA CLINICAL LABORATORY TESTS MARKET SIZE, BY BASIC METABOLIC PANEL, 2018-2030 (USD MILLION)
• TABLE 76. CHINA CLINICAL LABORATORY TESTS MARKET SIZE, BY COMPREHENSIVE METABOLIC PANEL, 2018-2030 (USD MILLION)
• TABLE 77. CHINA CLINICAL LABORATORY TESTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 78. CHINA CLINICAL LABORATORY TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 79. INDIA CLINICAL LABORATORY TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 80. INDIA CLINICAL LABORATORY TESTS MARKET SIZE, BY BASIC METABOLIC PANEL, 2018-2030 (USD MILLION)
• TABLE 81. INDIA CLINICAL LABORATORY TESTS MARKET SIZE, BY COMPREHENSIVE METABOLIC PANEL, 2018-2030 (USD MILLION)
• TABLE 82. INDIA CLINICAL LABORATORY TESTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 83. INDIA CLINICAL LABORATORY TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 84. INDONESIA CLINICAL LABORATORY TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 85. INDONESIA CLINICAL LABORATORY TESTS MARKET SIZE, BY BASIC METABOLIC PANEL, 2018-2030 (USD MILLION)
• TABLE 86. INDONESIA CLINICAL LABORATORY TESTS MARKET SIZE, BY COMPREHENSIVE METABOLIC PANEL, 2018-2030 (USD MILLION)
• TABLE 87. INDONESIA CLINICAL LABORATORY TESTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 88. INDONESIA CLINICAL LABORATORY TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 89. JAPAN CLINICAL LABORATORY TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 90. JAPAN CLINICAL LABORATORY TESTS MARKET SIZE, BY BASIC METABOLIC PANEL, 2018-2030 (USD MILLION)
• TABLE 91. JAPAN CLINICAL LABORATORY TESTS MARKET SIZE, BY COMPREHENSIVE METABOLIC PANEL, 2018-2030 (USD MILLION)
• TABLE 92. JAPAN CLINICAL LABORATORY TESTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 93. JAPAN CLINICAL LABORATORY TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 94. MALAYSIA CLINICAL LABORATORY TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 95. MALAYSIA CLINICAL LABORATORY TESTS MARKET SIZE, BY BASIC METABOLIC PANEL, 2018-2030 (USD MILLION)
• TABLE 96. MALAYSIA CLINICAL LABORATORY TESTS MARKET SIZE, BY COMPREHENSIVE METABOLIC PANEL, 2018-2030 (USD MILLION)
• TABLE 97. MALAYSIA CLINICAL LABORATORY TESTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 98. MALAYSIA CLINICAL LABORATORY TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 99. PHILIPPINES CLINICAL LABORATORY TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 100. PHILIPPINES CLINICAL LABORATORY TESTS MARKET SIZE, BY BASIC METABOLIC PANEL, 2018-2030 (USD MILLION)
• TABLE 101. PHILIPPINES CLINICAL LABORATORY TESTS MARKET SIZE, BY COMPREHENSIVE METABOLIC PANEL, 2018-2030 (USD MILLION)
• TABLE 102. PHILIPPINES CLINICAL LABORATORY TESTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 103. PHILIPPINES CLINICAL LABORATORY TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 104. SINGAPORE CLINICAL LABORATORY TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 105. SINGAPORE CLINICAL LABORATORY TESTS MARKET SIZE, BY BASIC METABOLIC PANEL, 2018-2030 (USD MILLION)
• TABLE 106. SINGAPORE CLINICAL LABORATORY TESTS MARKET SIZE, BY COMPREHENSIVE METABOLIC PANEL, 2018-2030 (USD MILLION)
• TABLE 107. SINGAPORE CLINICAL LABORATORY TESTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 108. SINGAPORE CLINICAL LABORATORY TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 109. SOUTH KOREA CLINICAL LABORATORY TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 110. SOUTH KOREA CLINICAL LABORATORY TESTS MARKET SIZE, BY BASIC METABOLIC PANEL, 2018-2030 (USD MILLION)
• TABLE 111. SOUTH KOREA CLINICAL LABORATORY TESTS MARKET SIZE, BY COMPREHENSIVE METABOLIC PANEL, 2018-2030 (USD MILLION)
• TABLE 112. SOUTH KOREA CLINICAL LABORATORY TESTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 113. SOUTH KOREA CLINICAL LABORATORY TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 114. TAIWAN CLINICAL LABORATORY TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 115. TAIWAN CLINICAL LABORATORY TESTS MARKET SIZE, BY BASIC METABOLIC PANEL, 2018-2030 (USD MILLION)
• TABLE 116. TAIWAN CLINICAL LABORATORY TESTS MARKET SIZE, BY COMPREHENSIVE METABOLIC PANEL, 2018-2030 (USD MILLION)
• TABLE 117. TAIWAN CLINICAL LABORATORY TESTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 118. TAIWAN CLINICAL LABORATORY TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 119. THAILAND CLINICAL LABORATORY TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 120. THAILAND CLINICAL LABORATORY TESTS MARKET SIZE, BY BASIC METABOLIC PANEL, 2018-2030 (USD MILLION)
• TABLE 121. THAILAND CLINICAL LABORATORY TESTS MARKET SIZE, BY COMPREHENSIVE METABOLIC PANEL, 2018-2030 (USD MILLION)
• TABLE 122. THAILAND CLINICAL LABORATORY TESTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 123. THAILAND CLINICAL LABORATORY TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 124. VIETNAM CLINICAL LABORATORY TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 125. VIETNAM CLINICAL LABORATORY TESTS MARKET SIZE, BY BASIC METABOLIC PANEL, 2018-2030 (USD MILLION)
• TABLE 126. VIETNAM CLINICAL LABORATORY TESTS MARKET SIZE, BY COMPREHENSIVE METABOLIC PANEL, 2018-2030 (USD MILLION)
• TABLE 127. VIETNAM CLINICAL LABORATORY TESTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 128. VIETNAM CLINICAL LABORATORY TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 129. EUROPE, MIDDLE EAST & AFRICA CLINICAL LABORATORY TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 130. EUROPE, MIDDLE EAST & AFRICA CLINICAL LABORATORY TESTS MARKET SIZE, BY BASIC METABOLIC PANEL, 2018-2030 (USD MILLION)
• TABLE 131. EUROPE, MIDDLE EAST & AFRICA CLINICAL LABORATORY TESTS MARKET SIZE, BY COMPREHENSIVE METABOLIC PANEL, 2018-2030 (USD MILLION)
• TABLE 132. EUROPE, MIDDLE EAST & AFRICA CLINICAL LABORATORY TESTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 133. EUROPE, MIDDLE EAST & AFRICA CLINICAL LABORATORY TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 134. EUROPE, MIDDLE EAST & AFRICA CLINICAL LABORATORY TESTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 135. DENMARK CLINICAL LABORATORY TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 136. DENMARK CLINICAL LABORATORY TESTS MARKET SIZE, BY BASIC METABOLIC PANEL, 2018-2030 (USD MILLION)
• TABLE 137. DENMARK CLINICAL LABORATORY TESTS MARKET SIZE, BY COMPREHENSIVE METABOLIC PANEL, 2018-2030 (USD MILLION)
• TABLE 138. DENMARK CLINICAL LABORATORY TESTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 139. DENMARK CLINICAL LABORATORY TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 140. EGYPT CLINICAL LABORATORY TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 141. EGYPT CLINICAL LABORATORY TESTS MARKET SIZE, BY BASIC METABOLIC PANEL, 2018-2030 (USD MILLION)
• TABLE 142. EGYPT CLINICAL LABORATORY TESTS MARKET SIZE, BY COMPREHENSIVE METABOLIC PANEL, 2018-2030 (USD MILLION)
• TABLE 143. EGYPT CLINICAL LABORATORY TESTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 144. EGYPT CLINICAL LABORATORY TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 145. FINLAND CLINICAL LABORATORY TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 146. FINLAND CLINICAL LABORATORY TESTS MARKET SIZE, BY BASIC METABOLIC PANEL, 2018-2030 (USD MILLION)
• TABLE 147. FINLAND CLINICAL LABORATORY TESTS MARKET SIZE, BY COMPREHENSIVE METABOLIC PANEL, 2018-2030 (USD MILLION)
• TABLE 148. FINLAND CLINICAL LABORATORY TESTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 149. FINLAND CLINICAL LABORATORY TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 150. FRANCE CLINICAL LABORATORY TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 151. FRANCE CLINICAL LABORATORY TESTS MARKET SIZE, BY BASIC METABOLIC PANEL, 2018-2030 (USD MILLION)
• TABLE 152. FRANCE CLINICAL LABORATORY TESTS MARKET SIZE, BY COMPREHENSIVE METABOLIC PANEL, 2018-2030 (USD MILLION)
• TABLE 153. FRANCE CLINICAL LABORATORY TESTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 154. FRANCE CLINICAL LABORATORY TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 155. GERMANY CLINICAL LABORATORY TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 156. GERMANY CLINICAL LABORATORY TESTS MARKET SIZE, BY BASIC METABOLIC PANEL, 2018-2030 (USD MILLION)
• TABLE 157. GERMANY CLINICAL LABORATORY TESTS MARKET SIZE, BY COMPREHENSIVE METABOLIC PANEL, 2018-2030 (USD MILLION)
• TABLE 158. GERMANY CLINICAL LABORATORY TESTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 159. GERMANY CLINICAL LABORATORY TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 160. ISRAEL CLINICAL LABORATORY TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 161. ISRAEL CLINICAL LABORATORY TESTS MARKET SIZE, BY BASIC METABOLIC PANEL, 2018-2030 (USD MILLION)
• TABLE 162. ISRAEL CLINICAL LABORATORY TESTS MARKET SIZE, BY COMPREHENSIVE METABOLIC PANEL, 2018-2030 (USD MILLION)
• TABLE 163. ISRAEL CLINICAL LABORATORY TESTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 164. ISRAEL CLINICAL LABORATORY TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 165. ITALY CLINICAL LABORATORY TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 166. ITALY CLINICAL LABORATORY TESTS MARKET SIZE, BY BASIC METABOLIC PANEL, 2018-2030 (USD MILLION)
• TABLE 167. ITALY CLINICAL LABORATORY TESTS MARKET SIZE, BY COMPREHENSIVE METABOLIC PANEL, 2018-2030 (USD MILLION)
• TABLE 168. ITALY CLINICAL LABORATORY TESTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 169. ITALY CLINICAL LABORATORY TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 170. NETHERLANDS CLINICAL LABORATORY TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 171. NETHERLANDS CLINICAL LABORATORY TESTS MARKET SIZE, BY BASIC METABOLIC PANEL, 2018-2030 (USD MILLION)
• TABLE 172. NETHERLANDS CLINICAL LABORATORY TESTS MARKET SIZE, BY COMPREHENSIVE METABOLIC PANEL, 2018-2030 (USD MILLION)
• TABLE 173. NETHERLANDS CLINICAL LABORATORY TESTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 174. NETHERLANDS CLINICAL LABORATORY TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 175. NIGERIA CLINICAL LABORATORY TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 176. NIGERIA CLINICAL LABORATORY TESTS MARKET SIZE, BY BASIC METABOLIC PANEL, 2018-2030 (USD MILLION)
• TABLE 177. NIGERIA CLINICAL LABORATORY TESTS MARKET SIZE, BY COMPREHENSIVE METABOLIC PANEL, 2018-2030 (USD MILLION)
• TABLE 178. NIGERIA CLINICAL LABORATORY TESTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 179. NIGERIA CLINICAL LABORATORY TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 180. NORWAY CLINICAL LABORATORY TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 181. NORWAY CLINICAL LABORATORY TESTS MARKET SIZE, BY BASIC METABOLIC PANEL, 2018-2030 (USD MILLION)
• TABLE 182. NORWAY CLINICAL LABORATORY TESTS MARKET SIZE, BY COMPREHENSIVE METABOLIC PANEL, 2018-2030 (USD MILLION)
• TABLE 183. NORWAY CLINICAL LABORATORY TESTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 184. NORWAY CLINICAL LABORATORY TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 185. POLAND CLINICAL LABORATORY TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 186. POLAND CLINICAL LABORATORY TESTS MARKET SIZE, BY BASIC METABOLIC PANEL, 2018-2030 (USD MILLION)
• TABLE 187. POLAND CLINICAL LABORATORY TESTS MARKET SIZE, BY COMPREHENSIVE METABOLIC PANEL, 2018-2030 (USD MILLION)
• TABLE 188. POLAND CLINICAL LABORATORY TESTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 189. POLAND CLINICAL LABORATORY TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 190. QATAR CLINICAL LABORATORY TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 191. QATAR CLINICAL LABORATORY TESTS MARKET SIZE, BY BASIC METABOLIC PANEL, 2018-2030 (USD MILLION)
• TABLE 192. QATAR CLINICAL LABORATORY TESTS MARKET SIZE, BY COMPREHENSIVE METABOLIC PANEL, 2018-2030 (USD MILLION)
• TABLE 193. QATAR CLINICAL LABORATORY TESTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 194. QATAR CLINICAL LABORATORY TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 195. RUSSIA CLINICAL LABORATORY TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 196. RUSSIA CLINICAL LABORATORY TESTS MARKET SIZE, BY BASIC METABOLIC PANEL, 2018-2030 (USD MILLION)
• TABLE 197. RUSSIA CLINICAL LABORATORY TESTS MARKET SIZE, BY COMPREHENSIVE METABOLIC PANEL, 2018-2030 (USD MILLION)
• TABLE 198. RUSSIA CLINICAL LABORATORY TESTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 199. RUSSIA CLINICAL LABORATORY TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 200. SAUDI ARABIA CLINICAL LABORATORY TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 201. SAUDI ARABIA CLINICAL LABORATORY TESTS MARKET SIZE, BY BASIC METABOLIC PANEL, 2018-2030 (USD MILLION)
• TABLE 202. SAUDI ARABIA CLINICAL LABORATORY TESTS MARKET SIZE, BY COMPREHENSIVE METABOLIC PANEL, 2018-2030 (USD MILLION)
• TABLE 203. SAUDI ARABIA CLINICAL LABORATORY TESTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 204. SAUDI ARABIA CLINICAL LABORATORY TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 205. SOUTH AFRICA CLINICAL LABORATORY TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 206. SOUTH AFRICA CLINICAL LABORATORY TESTS MARKET SIZE, BY BASIC METABOLIC PANEL, 2018-2030 (USD MILLION)
• TABLE 207. SOUTH AFRICA CLINICAL LABORATORY TESTS MARKET SIZE, BY COMPREHENSIVE METABOLIC PANEL, 2018-2030 (USD MILLION)
• TABLE 208. SOUTH AFRICA CLINICAL LABORATORY TESTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 209. SOUTH AFRICA CLINICAL LABORATORY TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 210. SPAIN CLINICAL LABORATORY TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 211. SPAIN CLINICAL LABORATORY TESTS MARKET SIZE, BY BASIC METABOLIC PANEL, 2018-2030 (USD MILLION)
• TABLE 212. SPAIN CLINICAL LABORATORY TESTS MARKET SIZE, BY COMPREHENSIVE METABOLIC PANEL, 2018-2030 (USD MILLION)
• TABLE 213. SPAIN CLINICAL LABORATORY TESTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 214. SPAIN CLINICAL LABORATORY TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 215. SWEDEN CLINICAL LABORATORY TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 216. SWEDEN CLINICAL LABORATORY TESTS MARKET SIZE, BY BASIC METABOLIC PANEL, 2018-2030 (USD MILLION)
• TABLE 217. SWEDEN CLINICAL LABORATORY TESTS MARKET SIZE, BY COMPREHENSIVE METABOLIC PANEL, 2018-2030 (USD MILLION)
• TABLE 218. SWEDEN CLINICAL LABORATORY TESTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 219. SWEDEN CLINICAL LABORATORY TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 220. SWITZERLAND CLINICAL LABORATORY TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 221. SWITZERLAND CLINICAL LABORATORY TESTS MARKET SIZE, BY BASIC METABOLIC PANEL, 2018-2030 (USD MILLION)
• TABLE 222. SWITZERLAND CLINICAL LABORATORY TESTS MARKET SIZE, BY COMPREHENSIVE METABOLIC PANEL, 2018-2030 (USD MILLION)
• TABLE 223. SWITZERLAND CLINICAL LABORATORY TESTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 224. SWITZERLAND CLINICAL LABORATORY TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 225. TURKEY CLINICAL LABORATORY TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 226. TURKEY CLINICAL LABORATORY TESTS MARKET SIZE, BY BASIC METABOLIC PANEL, 2018-2030 (USD MILLION)
• TABLE 227. TURKEY CLINICAL LABORATORY TESTS MARKET SIZE, BY COMPREHENSIVE METABOLIC PANEL, 2018-2030 (USD MILLION)
• TABLE 228. TURKEY CLINICAL LABORATORY TESTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 229. TURKEY CLINICAL LABORATORY TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 230. UNITED ARAB EMIRATES CLINICAL LABORATORY TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 231. UNITED ARAB EMIRATES CLINICAL LABORATORY TESTS MARKET SIZE, BY BASIC METABOLIC PANEL, 2018-2030 (USD MILLION)
• TABLE 232. UNITED ARAB EMIRATES CLINICAL LABORATORY TESTS MARKET SIZE, BY COMPREHENSIVE METABOLIC PANEL, 2018-2030 (USD MILLION)
• TABLE 233. UNITED ARAB EMIRATES CLINICAL LABORATORY TESTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 234. UNITED ARAB EMIRATES CLINICAL LABORATORY TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 235. UNITED KINGDOM CLINICAL LABORATORY TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 236. UNITED KINGDOM CLINICAL LABORATORY TESTS MARKET SIZE, BY BASIC METABOLIC PANEL, 2018-2030 (USD MILLION)
• TABLE 237. UNITED KINGDOM CLINICAL LABORATORY TESTS MARKET SIZE, BY COMPREHENSIVE METABOLIC PANEL, 2018-2030 (USD MILLION)
• TABLE 238. UNITED KINGDOM CLINICAL LABORATORY TESTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 239. UNITED KINGDOM CLINICAL LABORATORY TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 240. CLINICAL LABORATORY TESTS MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 241. CLINICAL LABORATORY TESTS MARKET, FPNV POSITIONING MATRIX, 2023

The Clinical Laboratory Tests Market was valued at USD 135.72 billion in 2023, expected to reach USD 145.31 billion in 2024, and is projected to grow at a CAGR of 7.27%, to USD 221.86 billion by 2030.

The scope of the clinical laboratory tests market encompasses various diagnostic and monitoring tests conducted in medical laboratories to evaluate patient health and aid in disease detection and prevention. These tests include routine blood tests, genetic testing, and specialized pathology assays. The necessity of these tests is driven by their crucial role in timely diagnosis, treatment evaluation, and health monitoring, supporting healthcare providers in clinical decision-making. Their application extends to hospitals, clinics, diagnostic labs, and research institutes, with end-users including healthcare professionals and patients seeking accurate health insights. Market growth is primarily influenced by rising prevalence of chronic diseases, an aging population, and increasing demand for early disease detection. Advances in personalized medicine and technological innovations like automation and integration of AI and big data analytics present significant opportunities. Companies should focus on developing user-friendly, cost-effective testing solutions and expanding into emerging markets to leverage these opportunities. However, market growth is challenged by regulatory compliance issues, high testing costs, and the complexity of biomedical data. There is also apprehension regarding the reliability of certain novel diagnostic technologies. Innovation areas promising business growth include point-of-care testing, home testing kits, and the integration of blockchain for secure and efficient data management. Furthermore, investing in R&D for developing biomarker-based testing can meet the demand for precision medicine. The competitive landscape of the market is characterized by rapid technological advancements and strategic collaborations between key players. Overall, the market nature is dynamic and competitive, with ongoing innovations presenting avenues for growth and differentiation. It is critical for stakeholders to stay agile and informed on regulatory trends and technological shifts to maintain relevance and compete effectively.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Clinical Laboratory Tests Market

The Clinical Laboratory Tests Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing prevalence of chronic diseases
  • Growing healthcare expenditure globally
  • Rising preference for personalized medicine
• Market Restraints
  • High cost associated with clinical laboratory tests
• Market Opportunities
  • Growing need for point-of-care testing
  • Integration of digital solutions with clinical laboratory testing
• Market Challenges
  • Stringent regulatory frameworks for clinical laboratory test

Porter's Five Forces: A Strategic Tool for Navigating the Clinical Laboratory Tests Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Clinical Laboratory Tests Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Clinical Laboratory Tests Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Clinical Laboratory Tests Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Clinical Laboratory Tests Market

A detailed market share analysis in the Clinical Laboratory Tests Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Clinical Laboratory Tests Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Clinical Laboratory Tests Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Clinical Laboratory Tests Market

A strategic analysis of the Clinical Laboratory Tests Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Clinical Laboratory Tests Market, highlighting leading vendors and their innovative profiles. These include Apollo Health and Lifestyle Limited, Arup Laboratories Inc., Bioscientia Healthcare GmbH, Biosino Bio-technology and Science Inc., Charles River Laboratories, Inc, Cinven Ltd., Clinical Reference Laboratory, Inc., DaVita Inc. by UnitedHealth Group Inc., Dr Lal PathLabs Pvt. Ltd, Eurofins Scientific SE, Fresenius Medical Care Holdings, Inc., Laboratory Corporation of America Holdings, LifeLabs, Merck KgaA, Metropolis Health Products Retail Pvt Ltd., Metropolis Healthcare, Novartis International AG, OPKO Health, Inc., PerkinElmer, Inc., Qiagen .N.V., Quest Diagnostics Incorporated, Siemens Healthineers AG, Sonic Healthcare Limited, SYNLAB Group, and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Clinical Laboratory Tests Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Test Type, market is studied across Basic Metabolic Panel, Complete Blood Count, Comprehensive Metabolic Panel, Lipid Profile, Thyroid Test, and Urinalysis. The Basic Metabolic Panel is further studied across Calcium, Electrolytes, Glucose, and Kidney Tests. The Comprehensive Metabolic Panel is further studied across Liver Tests and Proteins.
• Based on Indication, market is studied across Autoimmune Diseases, Cardiovascular Diseases, Genetic Disorders, Infectious Diseases, and Oncological Diseases.
• Based on End-User, market is studied across Hospital-Based Laboratories and Independent Laboratories.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing prevalence of chronic diseases
    • 5.1.1.2. Growing healthcare expenditure globally
    • 5.1.1.3. Rising preference for personalized medicine
  • 5.1.2. Restraints
    • 5.1.2.1. High cost associated with clinical laboratory tests
  • 5.1.3. Opportunities
    • 5.1.3.1. Growing need for point-of-care testing
    • 5.1.3.2. Integration of digital solutions with clinical laboratory testing
  • 5.1.4. Challenges
    • 5.1.4.1. Stringent regulatory frameworks for clinical laboratory test
• 5.2. Market Segmentation Analysis
  • 5.2.1. Test Type: Growing utilization of comprehensive metabolic panel as provides foundational metabolic information with more comprehensive view
  • 5.2.2. Indication: Advancements in the genetic disorder testing with growing significance of predictive analytics and precision medicine
  • 5.2.3. End-User: Increasing preference for independent laboratories due to its broader reach and cost-effectivity
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Clinical Laboratory Tests Market, by Test Type

• 6.1. Introduction
• 6.2. Basic Metabolic Panel
  • 6.2.1. Calcium
  • 6.2.2. Electrolytes
  • 6.2.3. Glucose
  • 6.2.4. Kidney Tests
• 6.3. Complete Blood Count
• 6.4. Comprehensive Metabolic Panel
  • 6.4.1. Liver Tests
  • 6.4.2. Proteins
• 6.5. Lipid Profile
• 6.6. Thyroid Test
• 6.7. Urinalysis

7. Clinical Laboratory Tests Market, by Indication

• 7.1. Introduction
• 7.2. Autoimmune Diseases
• 7.3. Cardiovascular Diseases
• 7.4. Genetic Disorders
• 7.5. Infectious Diseases
• 7.6. Oncological Diseases

8. Clinical Laboratory Tests Market, by End-User

• 8.1. Introduction
• 8.2. Hospital-Based Laboratories
• 8.3. Independent Laboratories

9. Americas Clinical Laboratory Tests Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Clinical Laboratory Tests Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Clinical Laboratory Tests Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
  • 12.3.1. Labcorp to Acquire Key BioReference Health Assets from OPKO Health, Expanding Clinical and Reproductive Health Services Nationwide
  • 12.3.2. Key Proteo Advances Newborn Care with New Laboratory for Early Genetic Disorder Screening
  • 12.3.3. BSI Teams Up with Nelson Labs to Streamline PPE Supply Chains and Simplify Global Regulatory Processes
  • 12.3.4. Oncquest Laboratories Partners with Shruti Clinical Laboratory to Boost Advanced Testing Services in Mumbai
  • 12.3.5. Redcliffe Labs Acquires Medicentre, Strengthening Market Presence in Southern Rajasthan and Advancing Nationwide Growth
  • 12.3.6. Quest Diagnostics Enhances Maine Healthcare with Key Asset Acquisition from Northern Light Laboratory
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Apollo Health and Lifestyle Limited
• 2. Arup Laboratories Inc.
• 3. Bioscientia Healthcare GmbH
• 4. Biosino Bio-technology and Science Inc.
• 5. Charles River Laboratories, Inc
• 6. Cinven Ltd.
• 7. Clinical Reference Laboratory, Inc.
• 8. DaVita Inc. by UnitedHealth Group Inc.
• 9. Dr Lal PathLabs Pvt. Ltd
• 10. Eurofins Scientific SE
• 11. Fresenius Medical Care Holdings, Inc.
• 12. Laboratory Corporation of America Holdings
• 13. LifeLabs
• 14. Merck KgaA
• 15. Metropolis Health Products Retail Pvt Ltd.
• 16. Metropolis Healthcare
• 17. Novartis International AG
• 18. OPKO Health, Inc.
• 19. PerkinElmer, Inc.
• 20. Qiagen .N.V.
• 21. Quest Diagnostics Incorporated
• 22. Siemens Healthineers AG
• 23. Sonic Healthcare Limited
• 24. SYNLAB Group
• 25. Thermo Fisher Scientific Inc.